These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19875511)

  • 41. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.
    Schneider R; Campbell M; Nasioulas G; Felber BK; Pavlakis GN
    J Virol; 1997 Jul; 71(7):4892-903. PubMed ID: 9188551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
    Bai J; Banda N; Lee NS; Rossi J; Akkina R
    Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration.
    Mesplède T; Leng J; Pham HT; Liang J; Quan Y; Han Y; Wainberg MA
    mBio; 2017 Apr; 8(2):. PubMed ID: 28377526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
    Matsukura M; Zon G; Shinozuka K; Robert-Guroff M; Shimada T; Stein CA; Mitsuya H; Wong-Staal F; Cohen JS; Broder S
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4244-8. PubMed ID: 2471199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.
    Lin MH; Sivakumaran H; Jones A; Li D; Harper C; Wei T; Jin H; Rustanti L; Meunier FA; Spann K; Harrich D
    Retrovirology; 2014 Dec; 11():121. PubMed ID: 25496916
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1.
    Bogerd HP; Echarri A; Ross TM; Cullen BR
    J Virol; 1998 Nov; 72(11):8627-35. PubMed ID: 9765402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.
    Luo Y; Yu H; Peterlin BM
    J Virol; 1994 Jun; 68(6):3850-6. PubMed ID: 8189522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
    Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
    J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
    Schwartz S; Felber BK; Pavlakis GN
    Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency.
    Pomerantz RJ; Seshamma T; Trono D
    J Virol; 1992 Mar; 66(3):1809-13. PubMed ID: 1738210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes.
    Ludwig E; Silberstein FC; van Empel J; Erfle V; Neumann M; Brack-Werner R
    J Virol; 1999 Oct; 73(10):8279-89. PubMed ID: 10482578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Co-expression of a trans-dominant negative mutant of the human immunodeficiency virus type 1 (HIV-1) Rev protein affects the Rev-dependent splicing pattern and expression of HIV-1 RNAs.
    Szilvay AM; Bøe SO; Kalland KH
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1965-1974. PubMed ID: 10466792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
    Robert-Guroff M; Popovic M; Gartner S; Markham P; Gallo RC; Reitz MS
    J Virol; 1990 Jul; 64(7):3391-8. PubMed ID: 2191150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
    Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
    Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.
    Nakaya T; Iwai S; Fujinaga K; Sato Y; Otsuka E; Ikuta K
    Antimicrob Agents Chemother; 1997 Feb; 41(2):319-25. PubMed ID: 9021186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1.
    Davis AJ; Li P; Burrell CJ
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1897-906. PubMed ID: 9266985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.
    Pierson TC; Zhou Y; Kieffer TL; Ruff CT; Buck C; Siliciano RF
    J Virol; 2002 Sep; 76(17):8518-31. PubMed ID: 12163571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 5' RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production.
    Butsch M; Hull S; Wang Y; Roberts TM; Boris-Lawrie K
    J Virol; 1999 Jun; 73(6):4847-55. PubMed ID: 10233946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.